Archived Insight | March 21, 2023

SECURE 2.0: What Plan Sponsors Need to Know

The long-awaited SECURE 2.0 bill has become law, introducing an array of new compliance challenges and considerations for plan sponsors. The culmination of a multi-year, bicameral, bipartisan effort, SECURE 2.0 contains roughly 90 separate provisions, each with its own effective date.

On March 21, Segal experts discussed how this new legislation may encourage plan sponsors to add emergency savings programs to help participants juggle short and long-term financial needs.

SECURE 2.0 What Plan Sponsors Need to Know

In this webinar...

You’ll come away with an understanding of:

  • Retirement and financial security provisions of SECURE 2.0
  • Implications of SECURE 2.0 for the design of emergency savings programs
  • Future of the employee experience in emergency savings programs

 

Webinar Replay

 

 

Speakers

Jonathan Price, Senior Vice President, National Retirement Practice Leader
Julia Zuckerman, Vice President, Senior Compliance Consultant
Megan Yost, Senior Vice President, Communications Consultant
Bennett Hadley, Financial Wellness Solution Leader

Get the Slides

Don’t have time to watch a video right now? No worries. Here is a copy of the slides from this session.

Download Now

See more insights

Asian Female Pharmacist Uses Computer To Check Inventory For A Drug

Designing and Negotiating Affordable Pharmacy Benefits

Learn how health plan sponsors can improve pharmacy benefit value through PBM contracting, formulary management and clinical oversight.

Health, Multiemployer Plans, Public Sector, Healthcare Industry, Higher Education, Corporate, Pharmaceutical, Healthcare Cost Management

Read Full Insight

Focused Business Woman Working On Laptop Computer Reading

Many Retirement Plans Must Be Amended by December 31, 2026

Learn which retirement plans must be amended by December 31, 2026 and how SECURE Act discretionary and required amendments differ.

Retirement, Compliance, Multiemployer Plans, Public Sector, Healthcare Industry, Higher Education, Corporate

Read Full Insight

Man Self Injecting GLP 1 Weight Loss Medication Pen At Home

GLP-1s Have Disrupted the Market for Other Diabetes Drugs

Segal’s SHAPE data shows how rising GLP-1 use coincided with declines in insulin, Metformin and DPP-4 inhibitor use.

Health, Multiemployer Plans, Public Sector, Healthcare Industry, Higher Education, Corporate, Pharmaceutical

Read Full Insight

This page is for informational purposes only and does not constitute legal, tax or investment advice. You are encouraged to discuss the issues raised here with your legal, tax and other advisors before determining how the issues apply to your specific situations.